Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126


Evidence of ongoing replication in a human immunodeficiency virus type 1 persistently infected cell line.

Olivares I, Sánchez-Jiménez C, Vieira CR, Toledano V, Gutiérrez-Rivas M, López-Galíndez C.

J Gen Virol. 2013 May;94(Pt 5):944-54. doi: 10.1099/vir.0.046573-0. Epub 2013 Jan 3.


Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.

Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD Jr.

J Exp Med. 1995 Apr 1;181(4):1493-505. Erratum in: J Exp Med 1999 Nov 1;190(9):following 1362.


Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

Vendrame D, Sourisseau M, Perrin V, Schwartz O, Mammano F.

J Virol. 2009 Oct;83(20):10527-37. doi: 10.1128/JVI.01235-09. Epub 2009 Aug 12.


Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.

Chiang G, Sassaroli M, Louie M, Chen H, Stecher VJ, Sperber K.

Clin Ther. 1996 Nov-Dec;18(6):1080-92.


Mutagen-mediated enhancement of HIV-1 replication in persistently infected cells.

Sánchez-Jiménez C, Olivares I, de Ávila Lucas AI, Toledano V, Gutiérrez-Rivas M, Lorenzo-Redondo R, Grande-Pérez A, Domingo E, López-Galíndez C.

Virology. 2012 Mar 15;424(2):147-53. doi: 10.1016/j.virol.2011.12.016. Epub 2012 Jan 21.


Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity.

Asin SN, Wildt-Perinic D, Mason SI, Howell AL, Wira CR, Fanger MW.

J Infect Dis. 2003 May 15;187(10):1522-33. Epub 2003 Apr 23.


Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.

Perez-Bercoff D, David A, Sudry H, Barré-Sinoussi F, Pancino G.

J Virol. 2003 Apr;77(7):4081-94.


Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E, et al.

J Virol. 1995 Feb;69(2):814-24.


Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.

Abdurahman S, Végvári A, Youssefi M, Levi M, Höglund S, Andersson E, Horal P, Svennerholm B, Balzarini J, Vahlne A.

Antimicrob Agents Chemother. 2008 Oct;52(10):3737-44. doi: 10.1128/AAC.00265-08. Epub 2008 Jul 21.


Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Sei S, Yang QE, O'Neill D, Yoshimura K, Nagashima K, Mitsuya H.

J Virol. 2000 May;74(10):4621-33.


Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.

Aquaro S, Bagnarelli P, Guenci T, De Luca A, Clementi M, Balestra E, Caliò R, Perno CF.

J Med Virol. 2002 Dec;68(4):479-88.


Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.

Geleziunas R, Arts EJ, Boulerice F, Goldman H, Wainberg MA.

Antimicrob Agents Chemother. 1993 Jun;37(6):1305-12.


Effect of target cell availability on HIV-1 production in vitro.

Schwartz EJ, Neumann AU, Teixeira AV, Bruggeman LA, Rappaport J, Perelson AS, Klotman PE.

AIDS. 2002 Feb 15;16(3):341-5.


Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.

Stürmer M, Dauer B, Moesch M, Haberl A, Mueller A, Locher L, Knecht G, Hanke N, Doerr HW, Staszewski S.

Antivir Ther. 2007;12(1):25-30.


Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha.

Monté D, Groux H, Raharinivo B, Plouvier B, Dewulf J, Clavel T, Grangette C, Torpier G, Auriault C, Capron A, et al.

Blood. 1992 May 15;79(10):2670-9.


A quantitative assay for HIV DNA integration in vivo.

Butler SL, Hansen MS, Bushman FD.

Nat Med. 2001 May;7(5):631-4.


Supplemental Content

Support Center